| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Penis | 29 | 2020 | 110 | 5.720 |
Why?
|
| Animals | 81 | 2022 | 1238 | 2.440 |
Why?
|
| Piperazines | 8 | 2014 | 24 | 2.300 |
Why?
|
| Rats | 64 | 2021 | 432 | 2.230 |
Why?
|
| Oxidative Stress | 11 | 2020 | 102 | 2.130 |
Why?
|
| Nitric Oxide Synthase | 17 | 2021 | 74 | 2.040 |
Why?
|
| Aging | 17 | 2020 | 101 | 2.030 |
Why?
|
| Male | 64 | 2022 | 1649 | 1.920 |
Why?
|
| Fibrosis | 20 | 2011 | 63 | 1.900 |
Why?
|
| Myocytes, Smooth Muscle | 6 | 2020 | 28 | 1.630 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 4 | 2019 | 9 | 1.530 |
Why?
|
| Nitric Oxide Synthase Type II | 15 | 2018 | 46 | 1.380 |
Why?
|
| Sulfones | 7 | 2012 | 17 | 1.380 |
Why?
|
| Apoptosis | 15 | 2020 | 162 | 1.220 |
Why?
|
| Phosphodiesterase Inhibitors | 7 | 2007 | 21 | 1.170 |
Why?
|
| Nitric Oxide | 7 | 2019 | 54 | 1.110 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2011 | 22 | 1.080 |
Why?
|
| Erectile Dysfunction | 8 | 2021 | 37 | 1.070 |
Why?
|
| Rats, Sprague-Dawley | 23 | 2019 | 179 | 0.970 |
Why?
|
| Muscle, Smooth | 9 | 2019 | 36 | 0.930 |
Why?
|
| Cyclic GMP | 3 | 2019 | 13 | 0.890 |
Why?
|
| Citrulline | 2 | 2019 | 7 | 0.840 |
Why?
|
| Receptors, Glucocorticoid | 11 | 2000 | 23 | 0.810 |
Why?
|
| Arginine | 2 | 2019 | 19 | 0.770 |
Why?
|
| Rats, Inbred F344 | 20 | 2014 | 60 | 0.770 |
Why?
|
| Neuroprotective Agents | 4 | 2012 | 6 | 0.750 |
Why?
|
| Hypothalamus | 5 | 2020 | 47 | 0.700 |
Why?
|
| Transforming Growth Factor beta1 | 6 | 2011 | 24 | 0.700 |
Why?
|
| Estradiol | 6 | 2008 | 50 | 0.700 |
Why?
|
| Immunohistochemistry | 19 | 2010 | 133 | 0.680 |
Why?
|
| Ginger | 1 | 2018 | 2 | 0.660 |
Why?
|
| Olacaceae | 1 | 2018 | 2 | 0.660 |
Why?
|
| Paullinia | 1 | 2018 | 2 | 0.660 |
Why?
|
| Spinal Cord | 7 | 2003 | 14 | 0.620 |
Why?
|
| Gene Expression | 9 | 2012 | 73 | 0.620 |
Why?
|
| Penile Induration | 6 | 2008 | 34 | 0.590 |
Why?
|
| Imidazoles | 2 | 2006 | 16 | 0.580 |
Why?
|
| Neurons | 6 | 2020 | 41 | 0.550 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 4 | 2021 | 8 | 0.550 |
Why?
|
| Cells, Cultured | 11 | 2019 | 164 | 0.520 |
Why?
|
| Ganglia | 1 | 2014 | 2 | 0.520 |
Why?
|
| Penile Erection | 8 | 2014 | 33 | 0.520 |
Why?
|
| Sulfonamides | 1 | 2014 | 10 | 0.520 |
Why?
|
| Adrenal Glands | 5 | 2006 | 12 | 0.510 |
Why?
|
| Estrogens | 2 | 2006 | 25 | 0.500 |
Why?
|
| Obesity | 4 | 2022 | 102 | 0.490 |
Why?
|
| Collagen | 7 | 2010 | 26 | 0.490 |
Why?
|
| Brain | 8 | 2016 | 55 | 0.490 |
Why?
|
| Glucocorticoids | 9 | 2008 | 39 | 0.480 |
Why?
|
| Mice | 16 | 2022 | 508 | 0.480 |
Why?
|
| Morphine | 4 | 2016 | 44 | 0.460 |
Why?
|
| Purines | 6 | 2014 | 15 | 0.450 |
Why?
|
| Sildenafil Citrate | 6 | 2014 | 17 | 0.450 |
Why?
|
| Ganglia, Autonomic | 1 | 2012 | 2 | 0.440 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2012 | 2 | 0.440 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2020 | 60 | 0.410 |
Why?
|
| Tyrosine | 2 | 2001 | 6 | 0.410 |
Why?
|
| Antioxidants | 1 | 2011 | 20 | 0.410 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 9 | 0.400 |
Why?
|
| Impotence, Vasculogenic | 5 | 2009 | 14 | 0.400 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 12 | 0.400 |
Why?
|
| Vascular Diseases | 3 | 2007 | 7 | 0.390 |
Why?
|
| Blotting, Western | 13 | 2009 | 116 | 0.390 |
Why?
|
| Transforming Growth Factor beta | 7 | 2008 | 81 | 0.390 |
Why?
|
| Vagina | 2 | 2009 | 7 | 0.390 |
Why?
|
| Disease Models, Animal | 8 | 2018 | 143 | 0.380 |
Why?
|
| Proprotein Convertase 2 | 4 | 2016 | 23 | 0.360 |
Why?
|
| In Situ Nick-End Labeling | 5 | 2010 | 19 | 0.360 |
Why?
|
| Female | 18 | 2022 | 1733 | 0.360 |
Why?
|
| Peripheral Nerves | 1 | 2008 | 2 | 0.350 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2009 | 22 | 0.340 |
Why?
|
| Cell Differentiation | 7 | 2020 | 79 | 0.330 |
Why?
|
| Muscle, Skeletal | 4 | 2011 | 87 | 0.330 |
Why?
|
| RNA, Messenger | 11 | 2013 | 167 | 0.320 |
Why?
|
| Up-Regulation | 4 | 2014 | 71 | 0.320 |
Why?
|
| Nitric Oxide Synthase Type I | 9 | 2012 | 30 | 0.310 |
Why?
|
| Calcitriol | 3 | 2012 | 7 | 0.310 |
Why?
|
| Genitalia, Male | 1 | 2007 | 2 | 0.310 |
Why?
|
| Appetite | 4 | 2020 | 13 | 0.300 |
Why?
|
| Pituitary-Adrenal System | 2 | 2006 | 9 | 0.300 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2006 | 16 | 0.300 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 9 | 0.290 |
Why?
|
| Carrier Proteins | 2 | 2003 | 22 | 0.290 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2003 | 20 | 0.290 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 93 | 0.290 |
Why?
|
| Neurosecretory Systems | 1 | 2006 | 1 | 0.280 |
Why?
|
| Hippocampus | 6 | 2008 | 13 | 0.280 |
Why?
|
| Actins | 4 | 2010 | 17 | 0.270 |
Why?
|
| Morphine Dependence | 2 | 2016 | 9 | 0.260 |
Why?
|
| Reproduction | 2 | 2002 | 8 | 0.260 |
Why?
|
| Adipose Tissue | 2 | 2022 | 42 | 0.260 |
Why?
|
| Analgesics, Opioid | 2 | 2016 | 35 | 0.260 |
Why?
|
| Biomarkers | 2 | 2021 | 58 | 0.260 |
Why?
|
| Humans | 13 | 2022 | 2493 | 0.250 |
Why?
|
| Arteries | 2 | 2020 | 13 | 0.250 |
Why?
|
| Mice, Knockout | 4 | 2016 | 112 | 0.240 |
Why?
|
| Dexamethasone | 7 | 2000 | 27 | 0.240 |
Why?
|
| Hypoglycemic Agents | 3 | 2010 | 83 | 0.240 |
Why?
|
| Cell Proliferation | 4 | 2018 | 110 | 0.240 |
Why?
|
| Animals, Newborn | 2 | 2020 | 54 | 0.240 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2013 | 13 | 0.230 |
Why?
|
| Nerve Tissue | 2 | 2014 | 5 | 0.230 |
Why?
|
| Adiposity | 2 | 2022 | 18 | 0.230 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2002 | 1 | 0.220 |
Why?
|
| Nerve Degeneration | 1 | 2002 | 1 | 0.220 |
Why?
|
| Telencephalon | 1 | 2002 | 1 | 0.220 |
Why?
|
| GAP-43 Protein | 1 | 2002 | 1 | 0.220 |
Why?
|
| Proprotein Convertase 1 | 3 | 2013 | 17 | 0.220 |
Why?
|
| Adrenalectomy | 6 | 1995 | 10 | 0.220 |
Why?
|
| Signal Transduction | 5 | 2012 | 180 | 0.220 |
Why?
|
| Pituitary Gland | 3 | 2013 | 35 | 0.220 |
Why?
|
| Muscle Development | 2 | 2012 | 22 | 0.210 |
Why?
|
| Nucleotides, Cyclic | 1 | 2021 | 1 | 0.210 |
Why?
|
| Arginine Vasopressin | 3 | 1998 | 45 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2009 | 148 | 0.210 |
Why?
|
| Benzhydryl Compounds | 2 | 2018 | 8 | 0.210 |
Why?
|
| Phenols | 2 | 2018 | 8 | 0.210 |
Why?
|
| Reactive Oxygen Species | 4 | 2007 | 36 | 0.210 |
Why?
|
| Narcotics | 2 | 2013 | 13 | 0.200 |
Why?
|
| Hyperphagia | 1 | 2020 | 7 | 0.200 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 19 | 0.190 |
Why?
|
| Corticosterone | 7 | 2000 | 24 | 0.190 |
Why?
|
| Pregnancy | 5 | 2022 | 305 | 0.190 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 3 | 2006 | 8 | 0.190 |
Why?
|
| Genetic Therapy | 3 | 2007 | 18 | 0.190 |
Why?
|
| Animal Feed | 1 | 2020 | 12 | 0.190 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 54 | 0.190 |
Why?
|
| Sex Characteristics | 3 | 2000 | 16 | 0.180 |
Why?
|
| Fibroblasts | 4 | 2009 | 26 | 0.180 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2019 | 9 | 0.180 |
Why?
|
| Nitrites | 1 | 2019 | 5 | 0.180 |
Why?
|
| Enzyme Inhibitors | 3 | 2011 | 45 | 0.180 |
Why?
|
| Stress, Physiological | 1 | 1999 | 10 | 0.180 |
Why?
|
| Stem Cell Transplantation | 2 | 2009 | 14 | 0.170 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 3 | 0.170 |
Why?
|
| RNA, Small Interfering | 3 | 2008 | 32 | 0.170 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2018 | 4 | 0.170 |
Why?
|
| Adipocytes | 1 | 2018 | 26 | 0.170 |
Why?
|
| Pituitary Neoplasms | 4 | 2001 | 11 | 0.170 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2008 | 9 | 0.160 |
Why?
|
| Thiazolidinediones | 2 | 2009 | 22 | 0.160 |
Why?
|
| Myostatin | 4 | 2011 | 47 | 0.160 |
Why?
|
| Prostatectomy | 2 | 2007 | 4 | 0.160 |
Why?
|
| Ovariectomy | 6 | 2001 | 18 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2008 | 13 | 0.150 |
Why?
|
| Down-Regulation | 3 | 2008 | 52 | 0.150 |
Why?
|
| Vardenafil Dihydrochloride | 2 | 2006 | 4 | 0.150 |
Why?
|
| Triazines | 2 | 2006 | 6 | 0.150 |
Why?
|
| Nociceptive Pain | 1 | 2016 | 3 | 0.150 |
Why?
|
| Rats, Inbred BN | 4 | 2005 | 10 | 0.150 |
Why?
|
| Receptors, Opioid, mu | 1 | 2016 | 14 | 0.140 |
Why?
|
| Diethylstilbestrol | 4 | 2001 | 6 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 1 | 2014 | 2 | 0.130 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 5 | 0.130 |
Why?
|
| Prolactin | 3 | 2001 | 21 | 0.130 |
Why?
|
| Transcriptome | 1 | 2014 | 18 | 0.130 |
Why?
|
| Cholecalciferol | 1 | 2014 | 7 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 9 | 0.130 |
Why?
|
| Cytokines | 1 | 2014 | 47 | 0.130 |
Why?
|
| Cholinergic Fibers | 2 | 2006 | 2 | 0.130 |
Why?
|
| Ornithine Decarboxylase | 2 | 1997 | 3 | 0.130 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 26 | 0.120 |
Why?
|
| Models, Animal | 3 | 2021 | 16 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2013 | 26 | 0.120 |
Why?
|
| Eating | 1 | 2013 | 18 | 0.120 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2013 | 18 | 0.120 |
Why?
|
| Denervation | 3 | 2007 | 6 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 10 | 0.110 |
Why?
|
| Pelvis | 1 | 2012 | 2 | 0.110 |
Why?
|
| Neurturin | 1 | 2012 | 2 | 0.110 |
Why?
|
| Organ Sparing Treatments | 1 | 2012 | 2 | 0.110 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 22 | 0.110 |
Why?
|
| Aorta | 2 | 2009 | 16 | 0.110 |
Why?
|
| Multipotent Stem Cells | 2 | 2010 | 9 | 0.110 |
Why?
|
| Allopurinol | 1 | 2011 | 2 | 0.110 |
Why?
|
| Decorin | 1 | 2011 | 2 | 0.110 |
Why?
|
| Molsidomine | 1 | 2011 | 4 | 0.100 |
Why?
|
| Nitric Oxide Donors | 1 | 2011 | 7 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 185 | 0.100 |
Why?
|
| Pituitary Gland, Anterior | 2 | 1993 | 16 | 0.100 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2011 | 2 | 0.100 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2011 | 2 | 0.100 |
Why?
|
| Epiregulin | 1 | 2011 | 2 | 0.100 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 4 | 0.100 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 8 | 0.100 |
Why?
|
| Stem Cells | 2 | 2008 | 28 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 21 | 0.100 |
Why?
|
| Xanthine Dehydrogenase | 1 | 2010 | 2 | 0.100 |
Why?
|
| Narcotic Antagonists | 3 | 2016 | 21 | 0.100 |
Why?
|
| Receptors, Pituitary Hormone | 1 | 1990 | 1 | 0.100 |
Why?
|
| Myoblasts | 2 | 2008 | 12 | 0.100 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1990 | 21 | 0.100 |
Why?
|
| Thyrotropin-Releasing Hormone | 2 | 2008 | 17 | 0.100 |
Why?
|
| Desoxycorticosterone | 3 | 1999 | 4 | 0.090 |
Why?
|
| Astrocytes | 3 | 1999 | 6 | 0.090 |
Why?
|
| Cell Shape | 1 | 2010 | 3 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2010 | 14 | 0.090 |
Why?
|
| Insulin | 1 | 2010 | 109 | 0.090 |
Why?
|
| Tissue Scaffolds | 1 | 2009 | 3 | 0.090 |
Why?
|
| Neurogenesis | 2 | 2020 | 8 | 0.090 |
Why?
|
| Time Factors | 4 | 2013 | 120 | 0.090 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2009 | 2 | 0.090 |
Why?
|
| Kidney Tubules | 1 | 2009 | 3 | 0.090 |
Why?
|
| Tunica Media | 1 | 2009 | 4 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2016 | 14 | 0.090 |
Why?
|
| Endothelium | 1 | 2008 | 4 | 0.090 |
Why?
|
| Random Allocation | 1 | 2008 | 15 | 0.090 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2008 | 7 | 0.090 |
Why?
|
| Colon | 1 | 2008 | 16 | 0.090 |
Why?
|
| Body Weight | 4 | 2013 | 65 | 0.080 |
Why?
|
| Caspase 2 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Mesoderm | 1 | 2008 | 9 | 0.080 |
Why?
|
| Rats, Inbred Strains | 5 | 2008 | 38 | 0.080 |
Why?
|
| Organ Size | 4 | 2001 | 33 | 0.080 |
Why?
|
| Carbolines | 1 | 2007 | 4 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2007 | 11 | 0.080 |
Why?
|
| Fetal Nutrition Disorders | 1 | 2007 | 9 | 0.080 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2007 | 4 | 0.080 |
Why?
|
| Densitometry | 2 | 1997 | 2 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 18 | 0.080 |
Why?
|
| Malnutrition | 1 | 2007 | 23 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 4 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 8 | 0.070 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2006 | 9 | 0.070 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 9 | 0.070 |
Why?
|
| Proprotein Convertases | 1 | 2006 | 13 | 0.070 |
Why?
|
| Hypothyroidism | 1 | 2006 | 6 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2006 | 14 | 0.070 |
Why?
|
| Rats, Wistar | 1 | 2006 | 35 | 0.070 |
Why?
|
| Diet | 2 | 2022 | 40 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 6 | 0.070 |
Why?
|
| Dyneins | 2 | 2003 | 4 | 0.070 |
Why?
|
| Mineralocorticoids | 3 | 2008 | 3 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2006 | 19 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2006 | 2 | 0.070 |
Why?
|
| Prosencephalon | 1 | 2006 | 2 | 0.070 |
Why?
|
| Steroids | 1 | 2006 | 7 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2013 | 68 | 0.070 |
Why?
|
| Germ Cells | 1 | 2005 | 4 | 0.070 |
Why?
|
| Cell Line | 3 | 2012 | 80 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 92 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 118 | 0.060 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2004 | 2 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 2 | 0.060 |
Why?
|
| Oxytocin | 2 | 2001 | 6 | 0.060 |
Why?
|
| Plasminogen Inactivators | 1 | 2004 | 2 | 0.060 |
Why?
|
| Rats, Zucker | 3 | 2009 | 16 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2004 | 29 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 18 | 0.060 |
Why?
|
| Mitochondria | 1 | 2004 | 26 | 0.060 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2003 | 3 | 0.060 |
Why?
|
| Fibrin | 1 | 2003 | 3 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2003 | 7 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 1993 | 39 | 0.060 |
Why?
|
| Receptors, Calcitriol | 2 | 2014 | 11 | 0.060 |
Why?
|
| Weaning | 1 | 2022 | 5 | 0.060 |
Why?
|
| Kinetics | 2 | 1999 | 44 | 0.060 |
Why?
|
| Septal Nuclei | 1 | 2002 | 1 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2002 | 2 | 0.060 |
Why?
|
| Peroxynitrous Acid | 1 | 2002 | 4 | 0.060 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 2 | 2020 | 10 | 0.050 |
Why?
|
| Computational Biology | 1 | 2021 | 1 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2021 | 1 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 1 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 4 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2021 | 24 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 5 | 0.050 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2001 | 16 | 0.050 |
Why?
|
| Levonorgestrel | 1 | 2001 | 1 | 0.050 |
Why?
|
| Galanin | 1 | 2001 | 1 | 0.050 |
Why?
|
| Progesterone Congeners | 1 | 2001 | 1 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 7 | 0.050 |
Why?
|
| Nitrates | 1 | 2001 | 6 | 0.050 |
Why?
|
| RNA | 1 | 2001 | 16 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2001 | 13 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2001 | 28 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 13 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 13 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 13 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2001 | 32 | 0.050 |
Why?
|
| Agouti-Related Protein | 1 | 2020 | 7 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 10 | 0.050 |
Why?
|
| Satiation | 1 | 2020 | 5 | 0.050 |
Why?
|
| Prolactinoma | 1 | 2000 | 2 | 0.050 |
Why?
|
| Carcinogens | 1 | 2000 | 4 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 31 | 0.050 |
Why?
|
| Avoidance Learning | 1 | 2000 | 1 | 0.050 |
Why?
|
| Pyramidal Cells | 1 | 2000 | 1 | 0.050 |
Why?
|
| Protein Transport | 2 | 2014 | 16 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2000 | 35 | 0.050 |
Why?
|
| Electroporation | 3 | 2006 | 10 | 0.050 |
Why?
|
| Plasmids | 3 | 2006 | 16 | 0.050 |
Why?
|
| Genetic Vectors | 3 | 2006 | 16 | 0.050 |
Why?
|
| Sodium Chloride, Dietary | 1 | 1999 | 1 | 0.050 |
Why?
|
| Vasopressins | 1 | 1999 | 7 | 0.050 |
Why?
|
| Ether | 1 | 1999 | 2 | 0.040 |
Why?
|
| Kidney | 2 | 2009 | 36 | 0.040 |
Why?
|
| Enzyme Induction | 2 | 2002 | 15 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 1995 | 7 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 8 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2018 | 7 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2018 | 8 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 1998 | 13 | 0.040 |
Why?
|
| Drug Implants | 2 | 2013 | 7 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 1995 | 19 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1998 | 2 | 0.040 |
Why?
|
| Reference Values | 2 | 1999 | 42 | 0.040 |
Why?
|
| Transfection | 2 | 2008 | 46 | 0.040 |
Why?
|
| Tissue Distribution | 3 | 2006 | 24 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2007 | 119 | 0.040 |
Why?
|
| Phagocytosis | 1 | 1997 | 15 | 0.040 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 1997 | 1 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1997 | 2 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 11 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1996 | 5 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 1996 | 8 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 5 | 0.040 |
Why?
|
| Naloxone | 1 | 2016 | 14 | 0.040 |
Why?
|
| Progesterone | 1 | 1996 | 9 | 0.040 |
Why?
|
| Drug Tolerance | 1 | 2016 | 23 | 0.040 |
Why?
|
| Radioimmunoassay | 2 | 2008 | 24 | 0.030 |
Why?
|
| Sex Factors | 2 | 1997 | 75 | 0.030 |
Why?
|
| In Situ Hybridization | 3 | 2001 | 9 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 11 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2014 | 26 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 1999 | 4 | 0.030 |
Why?
|
| Testis | 2 | 2005 | 16 | 0.030 |
Why?
|
| Bromocriptine | 1 | 1993 | 1 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2013 | 5 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 8 | 0.030 |
Why?
|
| Motor Neurons | 1 | 1993 | 2 | 0.030 |
Why?
|
| Neuroglia | 1 | 1993 | 2 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 24 | 0.030 |
Why?
|
| Naltrexone | 1 | 2013 | 15 | 0.030 |
Why?
|
| Hypertension | 2 | 2008 | 56 | 0.030 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2012 | 3 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2012 | 5 | 0.030 |
Why?
|
| Flunitrazepam | 1 | 1992 | 1 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 1992 | 4 | 0.030 |
Why?
|
| beta-Galactosidase | 2 | 2002 | 6 | 0.030 |
Why?
|
| Adenoviridae | 2 | 2002 | 9 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2002 | 10 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2002 | 18 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 21 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 30 | 0.030 |
Why?
|
| Growth Differentiation Factors | 1 | 2011 | 2 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 4 | 0.030 |
Why?
|
| MyoD Protein | 1 | 2011 | 5 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 6 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 7 | 0.030 |
Why?
|
| Cytosol | 2 | 2000 | 10 | 0.020 |
Why?
|
| Receptors, Corticotropin | 1 | 1990 | 1 | 0.020 |
Why?
|
| Pituitary Gland, Posterior | 1 | 1990 | 3 | 0.020 |
Why?
|
| Spironolactone | 1 | 1990 | 3 | 0.020 |
Why?
|
| Castration | 1 | 1990 | 14 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2010 | 2 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2010 | 2 | 0.020 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 2 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 28 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 36 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2009 | 4 | 0.020 |
Why?
|
| Uterine Prolapse | 1 | 2009 | 4 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2009 | 7 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 16 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 8 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 3 | 0.020 |
Why?
|
| Isatin | 1 | 1989 | 1 | 0.020 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1989 | 1 | 0.020 |
Why?
|
| Myocardium | 1 | 1989 | 15 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2009 | 45 | 0.020 |
Why?
|
| Myenteric Plexus | 1 | 2008 | 3 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 13 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 14 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1989 | 20 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 4 | 0.020 |
Why?
|
| Reaction Time | 1 | 2008 | 8 | 0.020 |
Why?
|
| Sheep | 1 | 2008 | 100 | 0.020 |
Why?
|
| Inflammation | 1 | 2009 | 44 | 0.020 |
Why?
|
| Cell Division | 2 | 1999 | 39 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2008 | 3 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2008 | 6 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2008 | 39 | 0.020 |
Why?
|
| Aldehydes | 1 | 2008 | 9 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 24 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 11 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 24 | 0.020 |
Why?
|
| Adrenal Cortex | 1 | 2008 | 1 | 0.020 |
Why?
|
| Fetus | 1 | 2008 | 96 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2008 | 10 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 33 | 0.020 |
Why?
|
| Phenotype | 1 | 2008 | 40 | 0.020 |
Why?
|
| Follistatin | 1 | 2008 | 18 | 0.020 |
Why?
|
| Tadalafil | 1 | 2007 | 4 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2007 | 3 | 0.020 |
Why?
|
| Arterioles | 1 | 2007 | 6 | 0.020 |
Why?
|
| Age Factors | 1 | 2007 | 90 | 0.020 |
Why?
|
| Lac Operon | 1 | 2006 | 4 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2006 | 6 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 9 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 15 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 114 | 0.020 |
Why?
|
| Base Sequence | 1 | 2006 | 65 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 43 | 0.020 |
Why?
|
| Aged | 1 | 2008 | 607 | 0.020 |
Why?
|
| Middle Aged | 1 | 2008 | 799 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 1 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2004 | 2 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2004 | 9 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2004 | 11 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2004 | 12 | 0.020 |
Why?
|
| Caspases | 1 | 2004 | 21 | 0.020 |
Why?
|
| Cerebral Cortex | 2 | 1997 | 8 | 0.020 |
Why?
|
| Pentoxifylline | 1 | 2003 | 3 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 1996 | 7 | 0.010 |
Why?
|
| Nervous System | 1 | 2003 | 2 | 0.010 |
Why?
|
| Vimentin | 1 | 2002 | 3 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2002 | 15 | 0.010 |
Why?
|
| Aldosterone | 2 | 1992 | 6 | 0.010 |
Why?
|
| Cell Count | 1 | 2001 | 10 | 0.010 |
Why?
|
| Orchiectomy | 1 | 2000 | 11 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2000 | 3 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 11 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 6 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2000 | 9 | 0.010 |
Why?
|
| Atrophy | 1 | 2000 | 3 | 0.010 |
Why?
|
| Dendrites | 1 | 2000 | 2 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2000 | 37 | 0.010 |
Why?
|
| Gliosis | 1 | 1999 | 1 | 0.010 |
Why?
|
| Thymidine | 1 | 1999 | 1 | 0.010 |
Why?
|
| Motor Neuron Disease | 1 | 1999 | 1 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1999 | 2 | 0.010 |
Why?
|
| Pregnatrienes | 1 | 1999 | 2 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 14 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1999 | 10 | 0.010 |
Why?
|
| Supraoptic Nucleus | 1 | 1998 | 1 | 0.010 |
Why?
|
| Drinking | 1 | 1998 | 8 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 43 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 1 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 1997 | 1 | 0.010 |
Why?
|
| Neck | 1 | 1997 | 1 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1997 | 4 | 0.010 |
Why?
|
| Feedback | 1 | 1993 | 6 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1992 | 2 | 0.010 |
Why?
|
| Septum Pellucidum | 1 | 1989 | 1 | 0.010 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 1989 | 2 | 0.010 |
Why?
|
| Catecholamines | 1 | 1989 | 5 | 0.010 |
Why?
|
| Heart | 1 | 1989 | 15 | 0.010 |
Why?
|